177 related articles for article (PubMed ID: 10566114)
21. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
[TBL] [Abstract][Full Text] [Related]
22. Effects of stimulant medication on cognitive performance of children with ADHD.
Gimpel GA; Collett BR; Veeder MA; Gifford JA; Sneddon P; Bushman B; Hughes K; Odell JD
Clin Pediatr (Phila); 2005 Jun; 44(5):405-11. PubMed ID: 15965546
[TBL] [Abstract][Full Text] [Related]
23. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.
Chacko A; Pelham WE; Gnagy EM; Greiner A; Vallano G; Bukstein O; Rancurello M
J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):249-57. PubMed ID: 15725969
[TBL] [Abstract][Full Text] [Related]
24. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Aman MG; Binder C; Turgay A
J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
[TBL] [Abstract][Full Text] [Related]
25. Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome.
Martens MA; Seyfer DL; Andridge RR; Foster JE; McClure KE; Coury DL
Res Dev Disabil; 2013 May; 34(5):1700-9. PubMed ID: 23500164
[TBL] [Abstract][Full Text] [Related]
26. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
Conners CK
Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
[No Abstract] [Full Text] [Related]
27. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment.
Connor DF
J Dev Behav Pediatr; 2002 Feb; 23(1 Suppl):S1-9. PubMed ID: 11875284
[TBL] [Abstract][Full Text] [Related]
28. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
29. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
Pelham WE; Swanson JM; Furman MB; Schwindt H
J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519
[TBL] [Abstract][Full Text] [Related]
30. Pemoline in ADHD.
Winsberg B; Barbato M
J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
[No Abstract] [Full Text] [Related]
31. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.
Santos K; Palmini A; Radziuk AL; Rotert R; Bastos F; Booij L; Fernandes BS
Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530
[TBL] [Abstract][Full Text] [Related]
32. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
33. Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence.
Smith BH; Pelham WE; Gnagy E; Yudell RS
J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):314-21. PubMed ID: 9519637
[TBL] [Abstract][Full Text] [Related]
34. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder.
Findling RL; Short EJ; Manos MJ
J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1441-7. PubMed ID: 11765290
[TBL] [Abstract][Full Text] [Related]
35. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
36. Methylphenidate dosing: twice daily versus three times daily.
Stein MA; Blondis TA; Schnitzler ER; O'Brien T; Fishkin J; Blackwell B; Szumowski E; Roizen NJ
Pediatrics; 1996 Oct; 98(4 Pt 1):748-56. PubMed ID: 8885956
[TBL] [Abstract][Full Text] [Related]
37. How high a dose of stimulant medication in adult attention deficit hyperactivity disorder?
Sachdev PS; Trollor JN
Aust N Z J Psychiatry; 2000 Aug; 34(4):645-50. PubMed ID: 10954396
[TBL] [Abstract][Full Text] [Related]
38. Pemoline-associated hepatic failure: a critical analysis of the literature.
Shevell M; Schreiber R
Pediatr Neurol; 1997 Jan; 16(1):14-6. PubMed ID: 9044395
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
40. A rare case of dependence on pemoline.
Bonnet U; Davids E
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1340-1. PubMed ID: 16600453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
